Pooja B Rasal¹*, Gaurav N Kasar², Akanksha D Punekar³, Pranoti P Nikam³, Madhuri B Nagare³, Vikas S Shinde¹ and Amol U Gayake⁴

¹Department of Pharmacology, SND College of Pharmacy, Babhulgaon (Yeola), India
²Department of Pharmacology, Divine College of Pharmacy, Satana (Nashik), India
³Department of Pharmaceutical Quality Assurance, SND College of Pharmacy, Babhulgaon (Yeola), India

*Corresponding Author: Pooja B Rasal, Department of Pharmacology, SND College of Pharmacy, Babhulgaon (Yeola), India.

Received: March 07, 2025; Published: March 31, 2025

Abstract

Fisetin is a plant-derived flavonoid found in various fruits, vegetables, and plants, such as strawberries, apples, and onions, that has garnered attention for its broad pharmacological activities. Fisetin, which has anti-inflammatory, anti-cancer, neuroprotective, and antioxidant benefits, is essential for shielding cells from oxidative stress, which contributes to the emergence of cancer, neurological diseases, and other long-term illnesses. It has been shown to modulate inflammatory pathways like NF-κB and MAPK, potentially aiding in managing diseases such as arthritis and cardiovascular disorders. Additionally, fisetin has demonstrated neuroprotective effects, improving cognitive functions and mitigating oxidative damage in neurodegenerative diseases like Alzheimer's and Parkinson's. Animal studies have further validated the therapeutic potential of fisetin, with rodent models showing enhanced memory, reduced neuroinflammation, and increased brain-derived neurotrophic factor (BDNF) levels. In cancer research, fisetin has been shown to inhibit tumor growth by inducing apoptosis and suppressing metastasis. Moreover, fisetin improves glucose metabolism in diabetic animal models, reducing hyperglycemia and improving insulin sensitivity, while also positively affecting lipid profiles, potentially reducing cardiovascular risks. The objective of this review is to evaluate the existing research on fisetin, focusing on its sources, pharmacological activities, and mechanisms of action, with an emphasis on findings from animal studies. It aims to provide insights into fisetin’s therapeutic potential for conditions like neurodegeneration, cancer, diabetes, and inflammation, offering a comprehensive reference for researchers and healthcare professionals. Keywords: fisetin, flavonoids, neuroprotection, anticancer, diabetes, antioxidant, animal studies, therapeutic potential.

Keywords: Fisetin; Flavonoids; Neuroprotection; Anticancer; Diabetes; Animal Studies

References

1. Qnais E., et al. “Exploring the therapeutic potential of fisetin: a comprehensive study on its anti-nociceptive and anti-inflammatory effects”. European Review for Medical and Pharmacological Sciences 21 (2023): 10773-10784.
2. Rahmani AH., et al. “The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment”. Molecules24 (2022): 9009.
3. Telrandhe UB., et al. “Exploring the Pharmacological Potential of Fisetin: A Comprehensive Review”. International Journal of Pharmaceutical Quality Assurance2 (2024): 1048-1055.
4. Antika Lucia and Dewi Rita. “Pharmacological aspects of fisetin”. Asian Pacific Journal of Tropical Biomedicine 11 (2021): 1.
5. Hassan SSU., et al. “The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress”. Frontiers in Pharmacology 13 (2022): 1015835.
6. Tang X., et al. “An Overview of Recent Advances in the Neuroprotective Potentials of Fisetin against Diverse Insults in Neurological Diseases and the Underlying Signaling Pathways”. Biomedicines 11 (2023): 2878.
7. Krishnakumar IM., et al. “Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study”. Journal of Nutritional Science 11 (2022): e74.
8. Szymczak J., et al. “Fisetin-In Search of Better Bioavailability-From Macro to Nano Modifications: A Review”. International Journal of Molecular Sciences18 (2023): 14158.
9. Park C., et al. “Fisetin Attenuated Oxidative Stress-Induced Cellular Damage in ARPE-19 Human Retinal Pigment Epithelial Cells Through Nrf2-Mediated Activation of Heme Oxygenase-1”. Frontiers in Pharmacology 13 (2022): 927898.
10. Farsad-Naeimi Alireza and Alizadeh Mohammad. “Antioxidant properties of the flavonoid fisetin: An updated review of in vivo and in vitro studies”. Trends in Food Science and Technology 70 (2017).
11. Xianling Dai., et al. “Fisetin represses oxidative stress and mitochondrial dysfunction in NAFLD through suppressing GRP78-mediated endoplasmic reticulum (ER) stress”. Journal of Functional Foods 90 (2022): 104954.
12. Joma Natali., et al. “Nanocarriers for natural polyphenol senotherapeutics”. Aging Cell 23 (2024): e14178.
13. Lin KH., et al. “Fisetin attenuates doxorubicin-induced cardiotoxicity by inhibiting the insulin-like growth factor II receptor apoptotic pathway through estrogen receptor-α/-β activation”. Phytotherapy Research 9 (2023): 3964-3981.
14. Lai M., et al. “Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF”. Journal of Ophthalmology 2023 (2023): 7951928.
15. Kwon TH. “A novel strategy employing the flavonoid fisetin to halt the progression of renal fibrosis in obstructive nephropathy”. Kidney Research and Clinical Practice 3 (2023): 282-285.
16. Rakshit D., et al. “Nanoformulated fisetin ameliorates Alzheimer's disease via reducing proinflammatory cytokines and activating the NRF2/HO-1 pathway”. Nanomedicine (Lond)30 (2024): 2537-2553.
17. Zhang P and Cui J. “Neuroprotective Effect of Fisetin Against the Cerebral Ischemia-Reperfusion Damage via Suppression of Oxidative Stress and Inflammatory Parameters”. Inflammation 4 (2021): 1490-1506.
18. Zhang J., et al. “Fisetin Prevents Acetaminophen-Induced Liver Injury by Promoting Autophagy”. Frontiers in Pharmacology 11 (2020): 162.
19. Vásquez-Reyes S., et al. “The Effects of Novel Co-Amorphous Naringenin and Fisetin Compounds on a Diet-Induced Obesity Murine Model”. Nutrients 24 (2024): 4425.
20. Kim TW. “Fisetin, an Anti-Inflammatory Agent, Overcomes Radioresistance by Activating the PERK-ATF4-CHOP Axis in Liver Cancer”. International Journal of Molecular Sciences 10 (2023): 9076.
21. Daniela Correia da Silva., et al. “Fisetin derivatives exhibit enhanced anti-inflammatory activity and modulation of endoplasmic reticulum stress”. International Immunopharmacology 119 (2023): 110178.
22. Molagoda IMN., et al. “Fisetin inhibits lipopolysaccharide-induced inflammatory response by activating β-catenin, leading to a decrease in endotoxic shock”. Scientific Report 11 (2021): 8377.
23. Asmaa H Okasha., et al. “Effects of Fisetin and Nicorandil on adjuvant-induced rheumatoid arthritis in rats: Emerging role of TLR4/NF-κ induced Pyroptosis, Nrf-2/HO-1, and OPG/RANKL pathways”. Cytokine 187 (2025): 156876.
24. Hada Y., et al. “Fisetin Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Macrophage. Biomed Research International 2021 (2021): 5570885.
25. Sahu BD., et al. “Fisetin, a dietary flavonoid, ameliorates experimental colitis in mice: Relevance of NF-κB signaling”. Journal of Nutritional Biochemistry 28 (2016): 171-182.
26. Ahmad A., et al. “Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice”. Molecular Neurobiology3 (2017): 2269-2285.
27. Jiang Y., et al. “The Neuroprotective Role of Fisetin in Different Neurological Diseases: a Systematic Review”. Molecular Neurobiology 60 (2023): 6383-6394.
28. Nabizadeh F. “Neuroprotective told of Fisetin in Alzheimer's disease: An overview of potential mechanism and clinical findings”. Neurology Letters 3 (2024): 14-25.
29. Patel MY., et al. “The neuroprotective effect of fisetin in the MPTP model of Parkinson's disease”. Journal of Parkinsons Disease4 (2012): 287-302.
30. Muhammad Shoaib Tahir., et al. “Mechanistic new insights of flavonols on neurodegenerative diseases”. Biomedicine and Pharmacotherapy 137 (2021): 111253.
31. Maher P. “How fisetin reduces the impact of age and disease on CNS function”. Frontier in Bioscience (Schol Ed)1 (2015): 58-82.
32. Emeka Anyanwu G., et al. “Fisetin attenuates AlCl3-induced neurodegeneration by modulating oxidative stress and inflammatory cytokine release in adult albino wistar rats”. Toxicology Reports 132024 (2021): 101812.
33. Long Tai Zheng., et al. “Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity”. International Immunopharmacology3 (2008): 484-494.
34. Zhou C., et al. “Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent”. European Journal of Medical Research 28 (2023): 297.
35. Rahmani AH., et al. “The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment”. Molecules 24 (2022): 9009.
36. Imran M., et al. “Fisetin: An anticancer perspective”. Food Science Nutrition1 (2020): 3-16.
37. Kumar RM., et al. “Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics”. Pharmaceuticals 2 (2023): 196.
38. Kammerud SC., et al. “Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis”. Lab Investigation 101 (2021): 1439-1448.
39. Buranrat B., et al. “Fisetin-induced cell death, apoptosis, and antimigratory effects in cholangiocarcinoma cells”. Journal of Applied Pharmaceutical Science 2 (2025): 096-105.
40. Talaat SM., et al. “Novel PEGylated cholephytosomes for targeting fisetin to breast cancer: in vitro appraisal and in vivo antitumoral studies”. Drug Delivery and Translational Research 14 (2024): 433-454.
41. Lee JW., et al. “Fisetin induces apoptosis in uterine leiomyomas through multiple pathways”. Scientific Report 10 (2020): 7993.
42. Pandey A and Trigun SK. “Fisetin induces apoptosis in colorectal cancer cells by suppressing autophagy and down-regulating nuclear factor erythroid 2-related factor 2 (Nrf2)”. Journal of Cell Biochemistry9 (2023): 1289-1308.
43. Zamanian MY., et al. “A comprehensive view on the fisetin impact on colorectal cancer in animal models: Focusing on cellular and molecular mechanisms”. Animal Models and Experimental Medicine 5 (2024): 591-605.
44. Zehra K., et al. “Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines”. Naunyn-Schmiedeberg's Archives of Pharmacology 397 (2024): 7913-7926.
45. Markowska A., et al. “Role of Fisetin in Selected Malignant Neoplasms in Women”. Nutrients 21 (2023): 4686.
46. Reyhaneh Farghadani and Rakesh Naidu. “The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)”. Biomedicine and Pharmacotherapy 165 (2023): 115170.
47. Chen J., et al. “The Fisetin on Anti-senescence of Hepatocellular Carcinoma Cell”. International Journal of Public Health and Medical Research1 (2024): 33 41.
48. Wang J and Huang S. “Fisetin inhibits the growth and migration in the A549 human lung cancer cell line via the ERK1/2 pathway”. Experimental and Therapeutic Medicine 3 (2018): 2667-2673.
49. Ling J., et al. “Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation”. Evidence-Based Complementary and Alternative Medicine 2022 (2022): 2383527.
50. Liu Y., et al. “Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis”. Journal of Ovarian Research 1 (2022): 57.
51. Sun X., et al. “Anti cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies”. International Journal of Molecular Medicine 2 (2018): 811-820.
52. Rahmani A H., et al. “The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment”. Molecules 24 (2022): 9009.
53. Afroze N., et al. “Fisetin deters cell proliferation, induces apoptosis, alleviates oxidative stress and inflammation in human cancer cells, HeLa”. International Journal of Molecular Sciences3 (2022): 1707.
54. Zhou C., et al. “Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent”. European Journal of Medical Research 1 (2023): 297.
55. Yan W., et al. “Fisetin inhibits the proliferation of gastric cancer cells and induces apoptosis through suppression of ERK 1/2 activation”. Oncology Letter6 (2018): 8442-8446.
56. Wang B., et al. “Bioactivity of Two Polyphenols Quercetin and Fisetin against Human Gastric Adenocarcinoma AGS Cells as Affected by Two Coexisting Proteins”. Molecules 9 (2022): 2877.
57. Afroze N., et al. “Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa”. International Journal of Molecular Sciences 3 (2022): 1707.
58. Li T., et al. “Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validation”. Nutritional Metab (Lond) 20 (2023): 51.
59. Shi YS., et al. “Fisetin attenuates metabolic dysfunction in mice challenged with a high-fructose diet”. Journal of Agricultural and Food Chemistry 31 (2018): 8291-8298.
60. Choi MS., et al. “Fisetin Alleviates hepatic and adipocyte fibrosis and insulin resistance in diet-induced obese mice”. Journal of Medicinal Food 10 (2020): 1019-1032.
61. Jozaa Z., et al. “Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R”. Saudi Pharmaceutical Journal1 (2021): 27-42.
62. Osama Y Althunibat., et al. “Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy, Life Sciences 221 (2019): 83-92.
63. Ma T., et al. “Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-alpha”. Molecular Biology Reports 46 (2018): 105-118.
64. Watanabe R., et al. “Protective effects of fisetin against 6-OHDA-induced apoptosis by activation of PI3K-Akt signaling in human neuroblastoma SH-SY5Y Cells”. Neurochemistry Research 43 (2021): 488-499.
65. Zhang L., et al. “Fisetin alleviates oxidative stress after traumatic brain injury via the Nrf2-ARE pathway”. Neurochemistry International 118 (2021): 304-313.
66. AL-Ishaq R K., et al. “Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels”. Biomolecules 9 (2019): 430.
67. Sattari M., et al. “The protective effects of fisetin in metabolic disorders: a focus on oxidative stress and associated events”. Journal of Diabetes and Metabolic Disorders 23 (2024): 1753-1771.
68. ALTamimi JZ., et al. “Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R”. Saudi Pharmaceutical Journal 1 (2021): 27-42.
69. Kumari S., et al. “Protective Role of Fisetin in STZ Induced Diabetic Nephropathy in Rats”. Journal of Pharmaceutical Research International30B (2023): 97-111.
70. Ge C., et al. “Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation”. Food Function5 (2019): 2970-2985.
71. Maher P., et al. “Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes”. PLoS One6 (2011): e21226.
72. Liou CJ., et al. “Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice”. Cellular Physiology and Biochemistry 5 (2018): 1870-1884.
73. Priyanka N Prem., et al. “Recent advances in potential of Fisetin in the management of myocardial ischemia-reperfusion injury-A systematic review”. Phytomedicine 101 (2022): 154123.
74. Shanky Garg., et al. “The molecular mechanism involved in cardioprotection by the dietary flavonoid fisetin as an agonist of PPAR-γ in a murine model of myocardial infarction”. Archives of Biochemistry and Biophysics 694 (2020): 108572.
75. Panneerselvam Mythily and T Devika. “Cardioprotective Effect Of Fisetin On Lysosomal Enzyme Activities Of Normal And Isoproterenol-Induced Myocardial Infarction In Male Wistar Rats”. Asian Journal Of Pharmaceutical And Clinical Research (2019): 516-519.
76. Shanmugam K., et al. “Fisetin confers cardioprotection against myocardial ischemia reperfusion injury by suppressing mitochondrial oxidative stress and mitochondrial dysfunction and inhibiting glycogen synthase kinase 3β activity”. Oxidative Medicine and Cellular Longevity (2018).
77. Khan J., et al. “Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns”. Molecules13 (2022): 4021.
78. Shanmugam Karthi., et al. “Fisetin Preserves Interfibrillar Mitochondria to Protect Against Myocardial Ischemia-Reperfusion Injury”. Cell Biochemistry and Biophysics 80 (2022): 10.
79. Long L., et al. “Protective effects of fisetin against myocardial ischemia/reperfusion injury”. Experimental and Therapeutic Medicine 5 (2020): 3177-3188.
80. Shanmugam K., et al. “Fisetin Attenuates Myocardial Ischemia-Reperfusion Injury by Activating the Reperfusion Injury Salvage Kinase (RISK) Signaling Pathway”. Frontiers in Pharmacology 12 (2021): 566470.
81. Lin KH., et al. “Bioactive flavone fisetin attenuates hypertension associated cardiac hypertrophy in H9c2 cells and in spontaneously hypertension rats”. Journal of Functional Foods 52 (2019): 212-218.
82. Liu L., et al. “Fisetin Alleviates Atrial Inflammation, Remodeling, and Vulnerability to Atrial Fibrillation after Myocardial Infarction”. International Heart Journal6 (2019): 1398-1406.
83. Rodius S., et al. “Fisetin protects against cardiac cell death through reduction of ROS production and caspases activity”. Scientific Report 10 (2020): 2896.
84. Zhao R., et al. “Exploring the anti-aging effects of fisetin in telomerase-deficient progeria mouse model. Peer Journal 11 (2023): e16463.
85. Lee E and Burns M. “The Effects of Fisetin on Reducing Biological Aging: A Pilot Study”. Alternative Therapies in Health and Medicine 9 (2024): 6-10.
86. Jharana Das., et al. “Fisetin prevents the aging-associated decline in relative spectral power of α, β and linked MUA in the cortex and behavioral alterations”. Experimental Gerontology 138 (2020): 111006.
87. Huard C A., et al. “Effects of Fisetin Treatment on Cellular Senescence of Various Tissues and Organs of Old Sheep”. Antioxidants8 (2023): 1646.
88. Maher Pamela. “How fisetin reduces the impact of age and disease on CNS function”. Frontiers in Bioscience 7 (2015): 58-82.
89. Chiang HM., et al. “Fisetin Ameliorated Photodamage by Suppressing the Mitogen-Activated Protein Kinase/Matrix Metalloproteinase Pathway and Nuclear Factor-κB Pathways”. Journal of Agricultural and Food Chemistry18 (2015): 4551-4560.
90. Park C., et al. “Fisetin Attenuated Oxidative Stress-Induced Cellular Damage in ARPE-19 Human Retinal Pigment Epithelial Cells Through Nrf2-Mediated Activation of Heme Oxygenase-1”. Frontiers in Pharmacology 13 (2022): 927898.
91. Jang HY., et al. “Fisetin Inhibits UVA-Induced Expression of MMP-1 and MMP-3 through the NOX/ROS/MAPK Pathway in Human Dermal Fibroblasts and Human Epidermal Keratinocytes”. International Journal of Molecular Sciences24 (2023): 17358.
92. Ay M. “Evaluation of fisetin as a potential inducer of mitochondrial biogenesis in SH-SY5Y neuronal cells”. Iranian Journal of Basic Medical Sciences11 (2023): 1320-1325.
93. Mahoney SA., et al. “Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence”. Aging Cell3 (2023): e14060.
94. Sivandzade F., et al. “NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches”. Redox Biology 21 (2019): 101059.
95. Sun Y., et al. “Fisetin inhibits inflammation and induces autophagy by mediating PI3K/AKT/mTOR signaling in LPS-induced RAW264.7 cells”. Food Nutrition Research (2021): 65.
96. Lani R., et al. “Fisetin Modulates Toll-like Receptor-Mediated Innate Antiviral Response in Chikungunya Virus-Infected Hepatocellular Carcinoma Huh7 Cells”. Immunology4 (2021): 703-719.
97. Paul P., et al. “Orally administered fisetin as an immuno-modulatory and therapeutic agent in a mouse model of chronic allergic airway disease”. Biomedical Research and Therapy7 (2019): 3262-3273.
98. Song Bocui., et al. “Suppressive effects of fisetin on mice T lymphocytes in vitro and in vivo”. The Journal of Surgical Research 185 (2013).
99. F Ioannone., et al. “Flavonoids and immune function, Diet, Immunity and Inflammation”. Woodhead Publishing (2013): 379-415.
100. Ashiqueali SA., et al. “Fisetin modulates the gut microbiota alongside biomarkers of senescence and inflammation in a DSS-induced murine model of colitis”. Geroscience 3 (2024): 3085-3103.
101. Jae-Dong Lee., et al. “Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models”. International Immunopharmacology3 (2009): 268-276.
102. Hada Y., et al. “Fisetin Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Macrophage”. Biomed Research International (2021): 5570885.

Citation

Citation: Pooja B Rasal., et al. “Fisetin: From Dietary Source to Therapeutic Possibilities"Acta Scientific Nutritional Health 9.4 (2025): 84-103.

Copyright

Copyright: © 2025 Pooja B Rasal., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.